|
1
|
Logan CY and Nusse R: The Wnt signaling
pathway in development and disease. Annu Rev Cell Dev Biol.
20:781–810. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Clevers H: Wnt/beta-catenin signaling in
development and disease. Cell. 127:469–480. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Clevers H and Nusse R: Wnt/β-catenin
signaling and disease. Cell. 149:1192–1205. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Eastman Q and Grosschedl R: Regulation of
LEF-1/TCF transcription factors by Wnt and other signals. Curr Opin
Cell Biol. 11:233–240. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Beier F, Lee RJ, Taylor AC, Pestell RG and
LuValle P: Identification of the cyclin D1 gene as a target of
activating transcription factor 2 in chondrocytes. Proc Natl Acad
Sci USA. 96:1433–1438. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
He TC, Sparks AB, Rago C, Hermeking H,
Zawel L, da Costa LT, Morin PJ, Vogelstein B and Kinzler KW:
Identification of c-MYC as a target of the APC pathway. Science.
281:1509–1512. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jho EH, Zhang T, Domon C, Joo CK, Freund
JN and Costantini F: Wnt/beta-catenin/Tcf signaling induces the
transcription of Axin2, a negative regulator of the signaling
pathway. Mol Cell Biol. 22:1172–1183. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wodarz A and Nusse R: Mechanisms of Wnt
signaling in development. Annu Rev Cell Dev Biol. 14:59–88. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Polakis P: Wnt signaling and cancer. Genes
Dev. 14:1837–1851. 2000.PubMed/NCBI
|
|
10
|
Takahashi M, Nakamura Y, Obama K and
Furukawa Y: Identification of SP5 as a downstream gene of the
beta-catenin/Tcf pathway and its enhanced expression in human colon
cancer. Int J Oncol. 27:1483–1487. 2005.PubMed/NCBI
|
|
11
|
Fujimura N, Vacik T, Machon O, Vlcek C,
Scalabrin S, Speth M, Diep D, Krauss S and Kozmik Z: Wnt-mediated
down-regulation of Sp1 target genes by a transcriptional repressor
Sp5. J Biol Chem. 282:1225–1237. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wallmen B, Schrempp M and Hecht A:
Intrinsic properties of Tcf1 and Tcf4 splice variants determine
cell-type-specific Wnt/β-catenin target gene expression. Nucleic
Acids Res. 40:9455–9469. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fancy SP, Harrington EP, Baranzini SE,
Silbereis JC, Shiow LR, Yuen TJ, Huang EJ, Lomvardas S and Rowitch
DH: Parallel states of pathological Wnt signaling in neonatal brain
injury and colon cancer. Nat Neurosci. 17:506–512. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen Y, Guo Y, Ge X, Itoh H, Watanabe A,
Fujiwara T, Kodama T and Aburatani H: Elevated expression and
potential roles of human Sp5, a member of Sp transcription factor
family, in human cancers. Biochem Biophys Res Commun. 340:758–766.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kadonaga JT, Carner KR, Masiarz FR and
Tjian R: Isolation of cDNA encoding transcription factor Sp1 and
functional analysis of the DNA binding domain. Cell. 51:1079–1090.
1987. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kadonaga JT, Courey AJ, Ladika J and Tjian
R: Distinct regions of Sp1 modulate DNA binding and transcriptional
activation. Science. 242:1566–1570. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hoverter NP, Ting JH, Sundaresh S, Baldi P
and Waterman ML: A WNT/p21 circuit directed by the C-clamp, a
sequence-specific DNA binding domain in TCFs. Mol Cell Biol.
32:3648–3662. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fernandez-Zapico ME, Lomberk GA, Tsuji S,
DeMars CJ, Bardsley MR, Lin YH, Almada LL, Han JJ, Mukhopadhyay D,
Ordog T, et al: A functional family-wide screening of SP/KLF
proteins identifies a subset of suppressors of KRAS-mediated cell
growth. Biochem J. 435:529–537. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Harrison SM, Houzelstein D, Dunwoodie SL
and Beddington RS: Sp5, a new member of the Sp1 family, is
dynamically expressed during development and genetically interacts
with Brachyury. Dev Biol. 227:358–372. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Matsuura K, Jigami T, Taniue K, Morishita
Y, Adachi S, Senda T, Nonaka A, Aburatani H, Nakamura T and Akiyama
T: Identification of a link between Wnt/β-catenin signalling and
the cell fusion pathway. Nat Commun. 2:5482011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sparks AB, Morin PJ, Vogelstein B and
Kinzler KW: Mutational analysis of the APC/beta-catenin/Tcf pathway
in colorectal cancer. Cancer Res. 58:1130–1134. 1998.PubMed/NCBI
|
|
23
|
Ilyas M, Tomlinson IP, Rowan A, Pignatelli
M and Bodmer WF: Beta-catenin mutations in cell lines established
from human colorectal cancers. Proc Natl Acad Sci USA.
94:10330–10334. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Herbst A, Jurinovic V, Krebs S, Thieme SE,
Blum H, Göke B and Kolligs FT: Comprehensive analysis of β-catenin
target genes in colorectal carcinoma cell lines with deregulated
Wnt/β-catenin signaling. BMC Genomics. 15:742014. View Article : Google Scholar : PubMed/NCBI
|
